Xian-Zong Ye

1.1k citations
9 papers · 897 indexed · h-index 7
  • Genetics top 5%
    • Glioma Diagnosis and Treatment 2
  • Immunology top 5%
    • Immune cells in cancer 4
    • Immune Response and Inflammation 1
  • Oncology top 10%
    • Cancer Cells and Metastasis 4
    • Viral-associated cancers and disorders 1
  • Neurology top 10%
    • Cholangiocarcinoma and Gallbladder Cancer Studies 1
    • Head and Neck Anomalies 1
    • Histiocytic Disorders and Treatments 1

Xian-Zong Ye

8 papers receiving 890 citations

Peers

Xian-Zong Ye
Comparison fields: 5 of 63
  • Genetics 235
  • Immunology 441
  • Oncology 418
  • Neurology 126
  • Cancer Research 216
Replace Katarzyna C. Pituch with:
Katarzyna C. Pituch United States
Verlene Henry United States
Sadhak Sengupta United States
Klara Soukup Austria
Anantha Marisetty United States
Cameron J. Herting United States
Sonali Arora United States
Brittany C. Parker Kerrigan United States
Tiffany Doucette United States
Magdalena Kijewska Poland
Xian-Zong Ye relative to Katarzyna C. Pituch United States Katarzyna C. Pituch's profile →
Citations per field
00.5×6.1×
Katarzyna C. Pituch · 1×
Citations per year

Countries citing papers authored by Xian-Zong Ye

Since Specialization
Citations

This map shows the geographic impact of Xian-Zong Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xian-Zong Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xian-Zong Ye more than expected).

Fields of papers citing papers by Xian-Zong Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xian-Zong Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xian-Zong Ye. The network helps show where Xian-Zong Ye may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xian-Zong Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xian-Zong Ye Line = papers co-authored together Xian-Zong Ye links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1 20240
2 20233
3 20186
4 2014174
5 201375
6 2012375
7 201174
8 2010126
9 201064

About Xian-Zong Ye

Xian-Zong Ye is a scholar working on Oncology, Immunology and Genetics, having authored 9 papers that have together received 897 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Cancer Cells and Metastasis (4 papers), Glioma Diagnosis and Treatment (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper), Viral-associated cancers and disorders (1 paper), Head and Neck Anomalies (1 paper), Immune Response and Inflammation (1 paper) and Histiocytic Disorders and Treatments (1 paper). The work is most often cited by research in Genetics (235 citations), Immunology (441 citations) and Oncology (418 citations). Xian-Zong Ye has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiu‐Wu Bian, Shi‐Cang Yu, Yi‐Fang Ping, Senlin Xu, Xia Zhang, Hualiang Xiao, Yi Liang, Cheng Qian, Lang Yang and You‐Hong Cui.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026